Valganciclovir For Solution
Product Images NDC 71151-003

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Valganciclovir (NDC 71151-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Airis Pharma Pvt Ltd, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure01)

An instructional diagram showing an oral dispenser and bottle components typically used with liquid medication. The bottle includes a child-resistant cap, bottle adapter, and bottle. The oral dispenser is labeled with plunger, barrel, and tip parts, with volume markings from 1 to 10 mL on the barrel.*

FDA Label Image

Math Formula (Formulla0001)

A formula image showing two medical calculations: Mosteller Body Surface Area (BSA) calculated as the square root of (Height in cm times Weight in kg divided by 3600), and Schwartz Creatinine Clearance estimated as the product of a constant k and Height in cm divided by Serum Creatinine in mg/dL.*

FDA Label Image

Image Description (Formulla0002)

Text showing a formula for males that calculates a value by taking (140 minus age in years) times body weight in kg, divided by 72 times serum creatinine in mg/dL. This is likely a clinical calculation related to the drug but no dosing or usage information is provided.*

FDA Label Image

Image Description (Image001)

Packaging label for Valganciclovir for Oral Solution 50 mg/1 mL, manufactured by airis PHARMA PVT LTD. The label shows a 100 mL (3.4 fl oz) bottle containing oral solution with the active ingredient valganciclovir. It includes preparation instructions, storage details, and dispensing information. The label also specifies the NDC 71151-003-01 and indicates the product is Rx only.*

FDA Label Image

Step1 (Step01)

An instructional illustration showing a hand holding and shaking a small oral solution bottle, with the text 'Shake well' and arrows indicating vertical shaking motion. This suggests proper handling of the VALGANCICLOVIR oral solution.*

FDA Label Image

Step2 (Step02)

An instructional illustration showing a vial with a cap, alongside an arrow pointing downward and a circular arrow indicating twisting or turning the cap to open or close it. This diagram likely guides users on how to open the vial cap securely before using the solution inside.*

FDA Label Image

Step3 (Step03)

An illustration showing an oral syringe with a dosage indicator scale measured in milliliters (mL). The diagram highlights the dosage indicator used to measure liquid medication volume accurately, relevant for administration of oral solution formulations like valganciclovir.*

FDA Label Image

Step4 (Step04)

An instructional line drawing showing a hand holding a syringe-like oral dosing device. The thumb is pressing down on a plunger, indicating how to measure or administer the liquid medication, suited for oral use.*

FDA Label Image

Step5 (Step05)

An instructional illustration showing a hand holding a graduated measuring device above a bottle labeled as having a 'bottle adapter opening.' The diagram indicates how to align or insert the measuring device into the bottle adapter opening for accurate liquid measurement or dispensing.*

FDA Label Image

Step6 (Step06)

An instructional illustration showing the preparation of valganciclovir oral solution. It depicts a hand holding an oral solution bottle inverted to fill a syringe with the solution, demonstrating how to draw the medication accurately using the syringe markings before oral administration.*

FDA Label Image

Step7 (Step07)

An instructional illustration showing a hand withdrawing liquid from an oral solution bottle with a syringe. The diagram demonstrates the upward motion used to draw the medication.*

FDA Label Image

Step8 (Step08)

An instructional line drawing showing a child receiving oral medication from a syringe held by another person. The image depicts the administration of an oral solution to a pediatric patient, illustrating the correct method of delivering liquid medication by mouth.*

FDA Label Image

Step9 (Step09)

An instructional line drawing showing the top portion of a medication bottle with a child-resistant cap. The illustration depicts an arrow indicating the direction to turn the cap to open the bottle, demonstrating how to remove the child-resistant closure by pressing and rotating.*

FDA Label Image

Step10a (Step10a1)

An instructional illustration showing water droplets falling from a faucet onto a syringe and a small container or vial, indicating preparation or dilution instructions for oral solution administration.*

FDA Label Image

Step10a2 (Step10a2)

VALGANCICLOVIR oral solution syringe measuring up to 10 mL. The syringe is clear with black measurement markings in milliliters, from 0 to 10 mL, and has a graduated scale for accurate dosing. No other labeling or packaging visible. The product is manufactured by airis PHARMA PVT LTD.*

FDA Label Image

Chemical Structure (Structure0001)

Chemical structure of valganciclovir hydrochloride, the active ingredient in VALGANCICLOVIR oral solution 50 mg/mL by airis PHARMA PVT LTD (NDC 71151-003). The structure depicts the molecular arrangement including its purine base and side chains.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.